66
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Helping patients who say they cannot sleep

Practical ways to evaluate and treat insomnia

, MD
Pages 127-142 | Published online: 30 Jun 2015

References

  • Mahowald MW, Kader G, Schenck CH. Clinical categories of sleep disorders I. Continuum 1997; 3(4): 35–65
  • NIH Consensus Development Conference Summary. Drugs and insomnia: the use of medication to promote sleep. JAMA 1984; 251(18): 2410–4
  • Stoller MK. Economic effects of insomnia. Clin Ther 1994; 16(5): 873–97
  • Hauri PJ. Insomnia. Clin Chest Med 1998; 19(1): 157–68
  • Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl 1998; 393: 39–43
  • Chang PP, Ford DE, Mead LA, et al. Insomnia in young men and subsequent depression: the Johns Hopkins Precursors Study. Am J Epidemiol 1997; 146(2): 105–14
  • American Sleep Disorders Association, Diagnostic Classification Steering Committee. The international classification of sleep disorders, revised: diagnostic and coding manual. Rochester, Minn: American Sleep Disorders Assn, 1997
  • Hauri PJ. Idiopathic insomnia. In: Gilman S, Goldstein GW, Waxman SG, eds. Neurobase. 1st ed. San Diego: Arbor Publishing, 1999
  • Bonnet MH, Arand DL. Physiological activation in patients with sleep state misperception. Psychosom Med 1997; 59(5): 533–40
  • Walters AS, Hening WA, Chokroverty S. Review and videotape recognition of idiopathic restless legs syndrome. Mov Disord 1991; 6(2): 105–10
  • Hening W, Allen R, Walters AS, et al. Motor functions and dysfunctions of sleep. In: Chokroverty S, ed. Sleep disorders medicine. 2d ed. Boston: Butterworth-Heinemann, 1999: 441–507
  • Seilhean D, Duyckaerts C, Hauw JJ. [Fatal familial insomnia and prion diseases.] Rev Neurol (Paris) 1995; 151 (4): 225–30 (Fre, Eng abstr)
  • Erman MK, Poceta SJ. Obstructive sleep apnea presenting as insomnia. Sleep Res 1993; 22: 194
  • Vgontzas AN, Kales A, Bixler EO, et al. Usefulness of Polysomnographie studies in the differential diagnosis of insomnia. Int J Neurosci 1995; 82(1–2): 47–60
  • Montagna P, Provini F, Plazzi G, et al. Propriospinal myoclonus upon relaxation and drowsiness: a cause of severe insomnia. Mov Disord 1997; 12(1): 66–72
  • Owens JF, Matthews KA. Sleep disturbance in healthy middle-aged women. Maturitas 1998; 30(1): 41–50
  • Krystal AD, Edinger J, Wohlgemuth W, et al. Sleep in peri-menopausal and postmenopausal women. Sleep Med Rev 1998; 2:243–53
  • Dominguez RA, Goldstein BJ, Jacobson AF, et al. A doubleblind placebo-controlled study of fluvoxamine and Imipramine in depression. J Clin Psychiatry 1985; 46(3): 84–7
  • O'Hanlon JF, Freeman H. Categorising the behavioural toxicities of antidepressants: proposals and requirements. (Editorial) Br J Psychiatry 1995; 166(4): 421–3
  • Leppik IE. Felbamate. Epilepsia 1995; 36(Suppl 2): 66–72S
  • Sadler M. Lamotrigine associated with insomnia. Epilepsia 1999; 40(3): 322–5
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Am Psychiatric Assn, 1994
  • Eaton WW, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995; 152(7): 967–72
  • Soldatos CR. Insomnia in relation to depression and anxiety: epidemiologic considerations. J Psychosom Res 1994; 38(Suppl 1): 3–8
  • Arand DL, Bonnet MH. Activity, arousal, and the MSLT in patients with insomnia. Sleep 1999; 22(Suppl 1): 135
  • American Sleep Disorders Association, Standards of Practice Committee. Practice parameters for the use of polysomnography in the evaluation of insomnia. Sleep 1995; 18(1): 55–7
  • Lichstein KL, Wilson NM, Noe SL, et al. Daytime sleepiness in insomnia: behavioral, biological and subjective indices. Sleep 1994; 17(8): 693–702
  • Hauri PJ, Wisbey J. Wrist actigraphy in insomnia. Sleep 1992; 15(4): 293–301
  • Hauri PJ, Wisbey J. Actigraphy and insomnia: a closer look. Part 2. Sleep 1994; 17(5): 408–10
  • American Sleep Disorders Association. Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep 1995; 18(4): 285–7
  • Sadeh A, Hauri PJ, Kripke DF, et al. The role of actigraphy in the evaluation of sleep disorders. Sleep 1995; 18(4): 288–302
  • Kripke DF, Mullaney DJ, Messin S, et al. Wrist actigraphic measures of sleep and rhythms. Electroencephalogr Clin Neurophysiol 1978; 44(5): 674–6
  • Sadeh A, Lavie P, Scher A, et al. Actigraphic home-monitoring sleep-disturbed and control infants and young children: a new method for pediatric assessment of sleep-wake patterns. Pediatrics 1991; 87(4): 494–9
  • Webster JB, Messin S, Mullaney DJ, et al. Transducer design and placement for activity recording. Med Biol Eng Comput 1982; 20(6): 741–4
  • Mullaney DJ, Kripke DF, Messin S. Wrist-actigraphic estimation of sleep time. Sleep 1980; 3(1): 83–92
  • Sadeh A, Alster J, Urbach D, et al. Actigraphically based automatic bedtime sleep-wake schedule: validity and clinical applications. In: Chase MH, Lydic R, O'Conner C, eds. Sleep research. Vol 18. Los Angeles: Brain Information Service/Brain Research Inst, 1989: 399
  • Sun ER, Chen CA, Ho G, et al. Iron and the restless legs syndrome. Sleep 1998; 21(4): 371–7
  • Johnson LC, Spinweber CL. Good and poor sleepers differ in Navy performance. Mil Med 1983; 148(9): 727–31
  • Spielman AJ, Nunes J, Glovinsky PB. Insomnia. Neurol Clin 1996; 14(3): 513–43
  • Hauri PJ. Can we mix behavioral therapy with hypnotics when treating insomniacs? Sleep 1997; 20(12): 1111–8
  • Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996; 100(3): 333–7
  • Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999; 22(3): 371–5
  • Hohagen F, Kappler C, Schramm E, et al. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening—temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep 1994; 17(6): 551–4
  • Becker PM, Ondo W, Sharon D. Encouraging initial response of restless legs syndrome to pramipexole. Neurology 1998; 51(4): 1221–3
  • Lin SC, Kaplan J, Burger CD, et al. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 1998; 73(6): 497–500
  • Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52(5): 944–50
  • Walters AS, Hening WA, Kavey N, et al. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988; 24(3): 455–8
  • Brodeur C, Montplaisir J, Godbout R, et al. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988; 38(12): 1845–8
  • Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized doubleblind trial of oxycodone versus placebo. Sleep 1993; 16(4): 327–32
  • Hening WA, Walters A, Kavey N, et al. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids. Neurology 1986; 36(10): 1363–6
  • Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry 1987; 50(12): 1679–81
  • Estevill-Sancho EX, De La Fuente-Panell V. Ropinirol as a successful treatment of the restless legs syndrome: an open pilot study with Polysomnographie data. Sleep 1999; 22(Suppl 1): 158S
  • Uhles ML, Duntley SP. Evaluation of the efficacy of neurontin in the treatment of restless legs syndrome. Sleep 1999; 22(Suppl 1): 157S
  • Salmi T, Punnonen R. Clonidine in the treatment of menopausal symptoms. Int J Gynaecol Obstet 1979; 16(5): 422–6
  • Wagner ML, Walters AS, Coleman RG, et al. Randomized, double-blind, placebo-controlled study of Clonidine in restless legs syndrome. Sleep 1996; 19(1): 52–8
  • Coope J. Hormonal and non-hormonal interventions for menopausal symptoms. Maturitas 1996; 23(2): 159–68

References

  • Bonnet MH, Arand DL. Hyperarousal and insomnia. Sleep Med Rev 1997; 1(2): 97–108
  • Bonnet MH, Arand DL, 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995; 18(7): 581–8
  • Broman JE, Lundh LG, Hetta J. Insufficient sleep in the general population. Neurophysiol Clin 1996; 26(1): 30–9
  • Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom 1998; 60(5): 610–5
  • Lamarche CH, Ogilvie RD. Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs, and normal sleepers. Sleep 1997; 20(9): 724–33
  • Hauri PJ. Insomnia. Clin Chest Med 1998; 19(1): 157–68
  • Merica H, Blois R, Gaillard JM. Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci 1993; 10(5): 1826–34
  • Vgontzas AN, Tsigos C, Bixler EO, et al. Chronic insomnia and the activity of the stress system: a preliminary study. J Psychosom Res 1998; 45(1 Spec No); 21–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.